# Lunaphore Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lunaphore-technologies

- Industry: Biotechnology
- Headquarters: Switzerland
- Website: www.lunaphore.com
- Total disclosed funding: $66M
- Latest round: Series D (Mar 23, 2023)
- Investors on record: 8

## About

Based in Switzerland, Lunaphore Technologies specializes in advanced solutions for spatial biology, providing innovative technologies that enhance biological research and data analysis.Lunaphore Technologies SA, founded in 2014 in Switzerland, develops cutting-edge technologies for spatial biology. The company has recently pivoted its business strategy, focusing on enhancing automation and high-throughput analysis. The founders, Diego Dupouy and Déborah Heintze, have backgrounds in scientific innovation. In June 2023, Lunaphore raised CHF 30.000 mn in a Series D funding round led by EGS Beteiligungen AG, which marks a significant milestone in their financial journey. The company has completed 11 deals to date, with the latest being on June 22, 2023.Lunaphore Technologies specializes in advanced solutions for spatial biology, primarily through its flagship product, COMET™, which is designed for fully automated spatial biology applications. This technology allows for rapid assay development and cohort analysis, enabling researchers to obtain high-dimensional insights from biological samples in a streamlined manner. The system provides users with the flexibility to utilize their preferred antibodies without proprietary constraints, enhancing productivity in laboratory settings. In addition to COMET™, the company offers SPYRE™, a tool for antibody panel development, and HORIZON™, a software solution that aids in the analysis of hyperplex immunofluorescence images. Lunaphore's products are primarily marketed to academic institutions, research organizations, and pharmaceutical companies in North America and Europe, supporting research across various fields, including immunology and oncology.Lunaphore Technologies generates revenue through direct sales of its products, providing laboratories with innovative tools to conduct advanced biological research. The company employs a B2B transaction structure, partnering with research institutions and university labs that require high-throughput analysis for their projects. Each sale typically includes the COMET™ system along with associated software and services, which may also feature ongoing support and training options, ensuring effective integration into the client's workflow. Pricing structures are designed to accommodate different scales of operation, enabling both smaller labs and larger research facilities to access Lunaphore's technology. Strategic partnerships with key players in the life sciences market further enhance Lunaphore's reach and funding capabilities, facilitating a sustainable revenue model focused on innovation and client satisfaction.In June 2023, Lunaphore Technologies was acquired by Bio-Techne Corporation, which is expected to drive new product development and market expansion initiatives. The company is planning to design and launch new products aimed at enhancing laboratory automation and spatial analysis capabilities. With recent funding, Lunaphore intends to leverage its technology to penetrate new markets in Asia and North America by the end of 2024, thereby supporting increasing demands for advanced biological analysis solutions.

## Funding rounds

- Series D, Mar 23, 2023, $32M — EGS Beteiligungen, Redalpine, PHC Holdings Corporation, Occident Group, Swiss Entrepreneurs Foundation
- Series C, Apr 21, 2020, $2M — Swiss Entrepreneurs Foundation
- Series C, Jan 15, 2020, $24M — Redalpine, PHC Holdings Corporation, Occident Group, Alpana Ventures
- Series B, Jul 1, 2017, $6.3M — Redalpine, Zuhlke Ventures, Polytech Ventures, Occident Group
- Series A, Apr 29, 2015, $2.1M — Redalpine

## Investors

- Redalpine (https://capitalatlas.ai/funds/redalpine) — Series A, Series B, Series C, Series D
- Zuhlke Ventures (https://capitalatlas.ai/funds/zuhlke-ventures) — Series B
- Polytech Ventures (https://capitalatlas.ai/funds/polytech-ventures) — Series B
- Occident Group — Series B, Series C, Series D
- PHC Holdings Corporation — Series C, Series D
- Alpana Ventures (https://capitalatlas.ai/funds/alpana-ventures) — Series C
- Swiss Entrepreneurs Foundation (https://capitalatlas.ai/funds/swiss-entrepreneurs-foundation) — Series C, Series D
- EGS Beteiligungen — Series D